Update and new approaches in the treatment of Castleman disease

por Chan, Kah-Lok, Lade, Stephen, Prince, H Miles, Harrison, Simon J
Publicado en J Blood Med (2016)

Rituximab is associated with improved survival for aggressive B cell CNS lymphoma(†)

por Gregory, Gareth, Arumugaswamy, Ashwini, Leung, Teresa, Chan, Kah-Lok, Abikhair, Melody, Tam, Constantine, Bajel, Ashish, Cher, Lawrence, Grigg, Andrew, Ritchie, David, Opat, Stephen
Publicado 2013

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

por Fox, Lucy C., Cummins, Katherine D., Costello, Ben, Yeung, David, Cleary, Rebecca, Forsyth, Cecily, Tatarczuch, Maciek, Burbury, Kate, Motorna, Olga, Shortt, Jake, Fleming, Shaun, McQuillan, Andrew, Schwarer, Anthony, Harrup, Rosemary, Holmes, Amy, Ratnasingam, Sumita, Chan, Kah-Lok, Hsu, Wei-Hsun, Ashraf, Asma, Putt, Faye, Grigg, Andrew
Publicado en Blood Adv (2017)

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia

por Minson, Adrian G., Cummins, Katherine, Fox, Lucy, Costello, Ben, Yeung, David, Cleary, Rebecca, Forsyth, Cecily, Tatarczuch, Maciek, Burbury, Kate, Motorna, Olga, Shortt, Jake, Fleming, Shaun, McQuillan, Andrew, Schwarer, Anthony, Harrup, Rosemary, Holmes, Amy, Ratnasingam, Sumita, Chan, Kah-Lok, Hsu, Wei-Hsun, Ashraf, Asma, Putt, Faye, Grigg, Andrew
Publicado en Blood Adv (2019)

Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes

por Sparbier, Christina E., Gillespie, Andrea, Gomez, Juliana, Kumari, Nishi, Motazedian, Ali, Chan, Kah Lok, Bell, Charles C., Gilan, Omer, Chan, Yih-Chih, Popp, Sarah, Gough, Daniel J., Eckersley-Maslin, Melanie A., Dawson, Sarah-Jane, Lehner, Paul J., Sutherland, Kate D., Ernst, Patricia, McGeehan, Gerard M., Lam, Enid Y. N., Burr, Marian L., Dawson, Mark A.
Publicado en Nat Cell Biol (2023)

Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses

por Chan, Kah Lok, Gomez, Juliana, Cardinez, Chelisa, Kumari, Nishi, Sparbier, Christina E., Lam, Enid Y.N., Yeung, Miriam M., Garciaz, Sylvain, Kuzich, James A., Ong, Doen Ming, Brown, Fiona C., Chan, Yih-Chih, Vassiliadis, Dane, Wainwright, Elanor N., Motazedian, Ali, Gillespie, Andrea, Fennell, Katie A., Lai, Junyun, House, Imran G., Macpherson, Laura, Ang, Ching-Seng, Dawson, Sarah-Jane, Beavis, Paul A., Wei, Andrew H., Burr, Marian L., Dawson, Mark A.
Publicado en Cancer Cell (2022)

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

por Burr, Marian L., Sparbier, Christina E., Chan, Kah Lok, Chan, Yih-Chih, Kersbergen, Ariena, Lam, Enid Y.N., Azidis-Yates, Elizabeth, Vassiliadis, Dane, Bell, Charles C., Gilan, Omer, Jackson, Susan, Tan, Lavinia, Wong, Stephen Q., Hollizeck, Sebastian, Michalak, Ewa M., Siddle, Hannah V., McCabe, Michael T., Prinjha, Rab K., Guerra, Glen R., Solomon, Benjamin J., Sandhu, Shahneen, Dawson, Sarah-Jane, Beavis, Paul A., Tothill, Richard W., Cullinane, Carleen, Lehner, Paul J., Sutherland, Kate D., Dawson, Mark A.
Publicado en Cancer Cell (2019)